DexCom will likely make significant headway in its addressable market in the next five years. The company should also increase its reach by launching new products and entering new countries ...

DexCom, Inc. (NASDAQ:DXCM) reported better-than-expected third-quarter results on Thursday. DexCom reported quarterly ...

DexCom's stock has declined 35% since my last bearish article, validating my "Sell" rating, though past bearish calls were incorrect as the stock previously doubled and tripled. Q3 results showed ...

Dexcom enjoys a well-established track record for introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, Dexcom has captured an ...

DexCom stock opened at $69.00 on Friday. The company’s 50-day moving average price is $69.70 and its 200-day moving average price is $94.48. DexCom has a twelve month low of $62.34 and a twelve ...

SAN DIEGO, October 24, 2024--DexCom, Inc. (Nasdaq ... producer and actress Retta to establish National Glucose Awareness Week from Sept. 23-29, 2024. National Glucose Awareness Week will help ...

Ithaka US Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that develops and ...

BofA raised the firm’s price target on DexCom (DXCM) to $90 from $80 and keeps a Buy rating on the shares post the Q3 report. DexCom did a good job instilling confidence in its 2025 revenue ...

Management maintained its full-year guidance for $4 billion to $4.05 billion in revenue. DexCom experienced slower growth and profitability challenges, but still met management's expectations for ...

DexCom reports quarterly earnings of 45 cents per share, which beat the analyst consensus estimate of 43 cents. Quarterly revenue comes in at $994.2 million, which beat the analyst consensus ...